Fluidigm Newswire

Fluidigm Newswire

Comprehensive Real-Time News Feed for Fluidigm.

Results 1 - 20 of 218 in Fluidigm

  1. Medical Transcription Billing, Corp. (MTBC) versus Fluidigm Corporation (FLDM) Head-To-Head ReviewRead the original story w/Photo

    Saturday | AmericanBankingNews.com

    Medical Transcription Billing, Corp. and Fluidigm Corporation are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitabiliy, valuation, institutional ownership, analyst recommendations, risk and dividends. 9.6% of Medical Transcription Billing, Corp. shares are held by institutional investors.

    Comment?

  2. Weiss Multi Strategy Advisers LLC Holds Stake in Fluidigm CorporationRead the original story w/Photo

    Friday Jul 21 | The Breeze

    Weiss Multi Strategy Advisers LLC continued to hold its position in shares of Fluidigm Corporation during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 100,000 shares of the medical research company's stock at the end of the first quarter.

    Comment?

  3. Critical Review: Fluidigm CorporationRead the original story w/Photo

    Tuesday Jul 18 | The Breeze

    Fluidigm Corporation and Cotiviti Holdings are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitabiliy, institutional ownership and dividends. This is a breakdown of recent ratings and recommmendations for Fluidigm Corporation and Cotiviti Holdings, as reported by MarketBeat.com.

    Comment?

  4. Fluidigm Introduces Immuno-Oncology Gene Expression Assay For...Read the original story

    Monday Jul 17 | BioSpace

    Fluidigm Corporation today announced the launch of the Advantaa Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven FluidigmA microfluidic technology. Designed for use with the Biomarka HD system, the Advanta Immuno-Oncology Gene Expression Assay sensitively detects 170 gene expression markers involved in checkpoint therapeutic response from FFPE and fresh frozen tumor samples.

    Comment?

  5. Fluidigm Corporation (NASDAQ:FLDM) Receiving Somewhat Favorable News Coverage, Study FindsRead the original story w/Photo

    Thursday Jul 13 | IntersportsWire

    Headlines about Fluidigm Corporation have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time.

    Comment?

  6. Fluidigm Corporation (FLDM) Downgraded by ValuEngine to "Strong Sell"Read the original story w/Photo

    Wednesday Jul 5 | IntersportsWire

    Other equities research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Fluidigm Corporation from a hold rating to a buy rating and set a $7.00 price target on the stock in a report on Thursday, February 9th.

    Comment?

  7. HealthEquity (HQY) and Fluidigm Corporation (FLDM) Head-To-Head AnalysisRead the original story w/Photo

    Wednesday Jul 5 | Daily Political

    HealthEquity and Fluidigm Corporation are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitabiliy, analyst recommendations, risk, institutional ownership and dividends. HealthEquity has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500.

    Comment?

  8. Global Circulating Tumor Cells Market 2017 : Janssen, ApoCell, Biocept, Fluidigm, Cynvenio and SysmexRead the original story w/Photo

    Wednesday Jul 5 | SBWire

    The survey report by Market Research Store is an overview of the global Circulating Tumor Cells market. It covers all the recent trends including key developments in the global market in present and in future.

    Comment?

  9. ValuEngine Lowers Fluidigm Corporation (FLDM) to Strong SellRead the original story w/Photo

    Wednesday Jul 5 | IntersportsWire

    Several other research analysts also recently commented on the company. Zacks Investment Research downgraded Fluidigm Corporation from a hold rating to a sell rating in a research note on Friday, May 12th.

    Comment?

  10. Fluidigm Corporation (FLDM) Receives Daily Coverage Optimism Score of 0.07Read the original story w/Photo

    Tuesday Jul 4 | Daily Political

    Press coverage about Fluidigm Corporation has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time.

    Comment?

  11. Fluidigm Corporation (NASDAQ:FLDM) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Tuesday Jul 4 | IntersportsWire

    According to Zacks, "Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit ; TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits ; and Access Array Assay Design Services.

    Comment?

  12. Somewhat Favorable Media Coverage Very Likely to Affect Fluidigm...Read the original story w/Photo

    Monday Jul 3 | IntersportsWire

    Complete the form below to receive the latest headlines and analysts' recommendationsfor Fluidigm Corporation with our free daily email newsletter: News headlines about Fluidigm Corporation have trended somewhat positive on Monday, according to Accern. Accern scores the sentiment of press coverage by analyzing more than 20 million blog and news sources.

    Comment?

  13. Reviewing Cotiviti HoldingsRead the original story w/Photo

    Thursday Jun 29 | IntersportsWire

    Fluidigm Corporation and Cotiviti Holdings are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitabiliy, analyst recommendations and institutional ownership. 92.2% of Fluidigm Corporation shares are held by institutional investors.

    Comment?

  14. Fluidigm Corporation (FLDM) Upgraded by Zacks Investment Research to "Hold"Read the original story w/Photo

    Saturday Jun 24 | IntersportsWire

    According to Zacks, "Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit ; TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits ; and Access Array Assay Design Services.

    Comment?

  15. Critical Contrast: NantHealthRead the original story w/Photo

    Saturday Jun 24 | Daily Political

    NantHealth and Fluidigm Corporation are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitabiliy, dividends and analyst recommendations. 92.2% of Fluidigm Corporation shares are held by institutional investors.

    Comment?

  16. Reviewing Tabula Rasa HealthcareRead the original story w/Photo

    Saturday Jun 24 | AmericanBankingNews.com

    Fluidigm Corporation and Tabula Rasa Healthcare are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitabiliy, risk, earnings, analyst recommendations and institutional ownership. 92.2% of Fluidigm Corporation shares are held by institutional investors.

    Comment?

  17. Fluidigm Corporation (FLDM) Given Daily Coverage Optimism Score of 0.02Read the original story w/Photo

    Jun 23, 2017 | IntersportsWire

    News coverage about Fluidigm Corporation has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time.

    Comment?

  18. ValuEngine Lowers Fluidigm Corporation (FLDM) to Strong SellRead the original story w/Photo

    Jun 20, 2017 | IntersportsWire

    Several other equities research analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Fluidigm Corporation from a hold rating to a sell rating in a report on Friday, May 12th.

    Comment?

  19. Fluidigm Corporation (FLDM) vs. NantHealth (NH) Critical AnalysisRead the original story w/Photo

    Jun 20, 2017 | The Breeze

    Fluidigm Corporation and NantHealth are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitabiliy and analyst recommendations. 92.2% of Fluidigm Corporation shares are held by institutional investors.

    Comment?

  20. Financial Comparison: NantHealthRead the original story w/Photo

    Jun 17, 2017 | AmericanBankingNews.com

    Fluidigm Corporation and NantHealth are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitabiliy. Fluidigm Corporation presently has a consensus target price of $10.50, suggesting a potential upside of 186.89%.

    Comment?